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Additional information regarding human placenta isolates
TRAIL is a ligand in the TNF family of ligands and functions to regulate
apoptosis in the immune system (Wiley et al., 1995).  TRAMP and TNFR1 are two
death-domain containing members of the large TNF receptor family that function in the
immune and inflammatory responses (Wallach et al., 1999).  TRAF2 is an adapter protein
that lies in the TNFa pathway (Rothe et al., 1995), while MyD88 functions in the IL-1
and Toll pathways (Medzhitov et al., 1998).  IKK-i/e, is an IKK-related kinase that is
induced by LPS and may play a role in PMA and TCR-mediated activation of NF-kB
(Peters et al., 2000; Shimada et al., 1999).  IKK-i/e is the closest homologue of TBK1
and both of these kinases can interact with the TANK adapter molecule (Nomura et al.,
2000; Pomerantz and Baltimore, 1999), possibly explaining why the IKK-i/e pool was the
only one inhibited by TBK1 K38A.  The small GTPase rhoB has been known to activate
NF-kB when overexpressed (Perona et al., 1997) but it has not been linked to a particular
signaling pathway to NF-kB.   The MARCKS protein is a protein kinase C substrate that
interacts with actin and calmodulin and is required for normal brain development
(Stumpo et al., 1995).  The DLK cell surface protein is a regulator of in vitro adipocyte
and hematopoetic differentiation (Moore et al., 1997; Smas and Sul, 1993). Snk is a
serum inducible kinase in the polo family (Simmons et al., 1992).
Additional information regarding mouse thymus isolates
The lymphotoxin b receptor (LTbR) (Nakamura et al., 1995) and CD40 (Torres
and Clark, 1992) are TNF receptor superfamily members required for lymphoid organ
development and thymus-dependent humoral immune responses, respectively (Wallach et
al., 1999). TAB2 (Takaesu et al., 2000) is an adapter implicated in the IL-1 pathway.
RIP3 (Sun et al., 1999; Yu et al., 1999) is an adapter that can induce apoptosis and NF-
kB activation.  NOD1 (Inohara et al., 1999) is an adapter implicated in the recognition of
intracellular lipopolysaccharide. The NIK kinase (Malinin et al., 1997) is required for
lymphoid organ development and functions in the processing of NF-kB2 p100 (Xiao et
al., 2001).
Note on factors contributing to the detection of molecules in the expression cloning
screen.
The detection of a particular molecule in our screen depends upon the frequency
of representation in the library of full-length cDNAs encoding it.  We isolated different
sets of molecules from the human placenta and mouse thymus libraries.  Each of these
screens only used small portions of the libraries and further screening will likely yield
other molecules. The mechanisms by which molecules activate signaling when
overexpressed may be extremely diverse. To be detected, a molecule must have the
capacity to initiate signaling when overexpressed in the particular cell line employed in
the screen.  This requires that the cell line contain other pathway components with which
the molecule can interact in order to signal.  These endogenous components may be
compatible for signaling with an overexpressed molecule even though they may not be
the bona fide, physiologically relevant signaling partners for the molecule in question.
The isolation of certain tissue-specific pathway components may require the use of a
particular appropriate cell line that uniquely supports signaling downstream of that
component.  The cDNA pool complexity (number of cDNAs per pool) determines the
minimum specific activity a molecule can possess and still be detected in the screen.  We
note that in our experience, the activity of a particular pool (the fold stimulation elicited)
was not predictive of the type of molecule responsible for the activity (see Table I).  It is
likely that the screening of less complex pools would have resulted in the detection of a
greater number and variety of molecules.
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